LYEONS is a neurotechnology company developing non-invasive, body-first solutions to support nervous system regulation and everyday neurohealth. Our technology uses gentle, heartbeat-like audio-tactile stimulation to provide the body with a physiological rhythm that may support calm, sleep, focus and resilience during moments of stress or overwhelm. Our first platform, the LYEONS Heart, is being developed through scientific research, human-centred design and ongoing collaboration with users, researchers and clinicians. Our work explores how sensory rhythms can influence physiological state, emotional regulation and cognitive performance. Our multidisciplinary team brings together expertise in neuroscience, engineering, clinical research, medical device development and lived experience. We are committed to translating promising neurotechnology into safe, accessible and meaningful solutions that people can use in everyday life. LYEONS is building a new generation of neurohealth technology at the intersection of neuroscience, physiology and human experience.
| Website | https://www.lyeons.com/ |
| Employees | 15 (7 on RocketReach) |
| Founded | 2024 |
| Industry | Technology, Information and Media |
Looking for a particular LYEONS Neurotech employee's phone or email?
Lucy Jung is the Founder I CEO of LYEONS Neurotech.
7 people are employed at LYEONS Neurotech.
LYEONS Neurotech is based in Cambridge, England.